Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer immunotherapy
2
×
clinical trials
deals
2
×
europe blog main
europe top stories
fda
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
acute myeloid leukemia
akouos
allergan
alnylam pharmaceuticals
alx oncology
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
autoimmune diseases
berkeley lights
biogen
biotech ipos
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
cd47
cerovene
chronic kidney disease
covid-19
What
ipo
2
×
acquisitions
announced
arrival
bio
biotech
ceo
collabs
companies
covid
daniel
days
deal
gilead
gilead’s
hasn’t
help
industry
introduce
ipos
life
market
medicines
momentum
month
new
o’day
plans
raised
research
roundup
science
sciences
slowed
street
summer’s
transformative
wall
week
welcomed
Language
unset
Current search:
fda
×
deals
×
ipo
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More